Single-subject analyses showed that one or more adverse events were reported in 14 children ( 41 % ) , and were evenly distributed between those with dextroamphetamine as the drug that showed the greatest reduction in their ADHD symptoms ( `` best drug '' ) and those with methylphenidate as their best drug .